KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases

Xiaozhong Guo, Helmut Friess, Hans U. Graber, Mikiya Kashiwagi, Arthur Zimmermann, Murray Korc, Markus W. Büchler

Research output: Contribution to journalArticle

165 Citations (Scopus)

Abstract

KAI1 is a metastasis suppressor gene for prostate cancer that is located on chromosome 11p11.2-13. Using Northern blot analysis and in situ hybridization, we studied expression of KAI1 mRNA in specimens from 14 normal pancreases and 27 primary pancreatic cancers, and then correlated the findings with the clinical and histopathological parameters of the patients. Northern blot analysis showed increased steady-state levels of KAI1 mRNA expression in 24 of 27 (89%) pancreatic cancer samples. In situ hybridization showed enhanced KAI1 mRNA levels in the pancreatic cancer cells in 82% cancer tissues. The stroma surrounding the cancer mass and normal pancreatic tissue adjacent to the cancer cells exhibited very low levels of KAI1 mRNA expression. Correlation of the mRNA levels obtained by Northern blot analysis with clinical parameters of the patients revealed that KAI1 mRNA levels were significantly higher (P <0.01) in earlier tumor stages (I, II), compared with advanced tumor stages (III, IV) in which lymph node or distant metastases were present. Furthermore, poorly differentiated tumors had significantly higher KAI1 mRNA levels than those that were moderately or well differentiated (P <0.05). No association between KAI1 expression and survival was found. Our results indicate that KAI1 mRNA expression is reduced in patients with advanced tumor stages. This suggests that reduction of KAI1 expression might enable pancreatic cancer cells to spread in lymph nodes and to distant organs.

Original languageEnglish (US)
Pages (from-to)4876-4880
Number of pages5
JournalCancer Research
Volume56
Issue number21
StatePublished - Nov 1 1996
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Neoplasm Metastasis
Messenger RNA
Neoplasms
Northern Blotting
In Situ Hybridization
Lymph Nodes
Chromosomes, Human, Pair 13
Tumor Suppressor Genes
Pancreas
Prostatic Neoplasms
Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Guo, X., Friess, H., Graber, H. U., Kashiwagi, M., Zimmermann, A., Korc, M., & Büchler, M. W. (1996). KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Research, 56(21), 4876-4880.

KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. / Guo, Xiaozhong; Friess, Helmut; Graber, Hans U.; Kashiwagi, Mikiya; Zimmermann, Arthur; Korc, Murray; Büchler, Markus W.

In: Cancer Research, Vol. 56, No. 21, 01.11.1996, p. 4876-4880.

Research output: Contribution to journalArticle

Guo, X, Friess, H, Graber, HU, Kashiwagi, M, Zimmermann, A, Korc, M & Büchler, MW 1996, 'KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases', Cancer Research, vol. 56, no. 21, pp. 4876-4880.
Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M et al. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Research. 1996 Nov 1;56(21):4876-4880.
Guo, Xiaozhong ; Friess, Helmut ; Graber, Hans U. ; Kashiwagi, Mikiya ; Zimmermann, Arthur ; Korc, Murray ; Büchler, Markus W. / KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. In: Cancer Research. 1996 ; Vol. 56, No. 21. pp. 4876-4880.
@article{678e3ab0b0244bf5bd1ef8630a1a8468,
title = "KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases",
abstract = "KAI1 is a metastasis suppressor gene for prostate cancer that is located on chromosome 11p11.2-13. Using Northern blot analysis and in situ hybridization, we studied expression of KAI1 mRNA in specimens from 14 normal pancreases and 27 primary pancreatic cancers, and then correlated the findings with the clinical and histopathological parameters of the patients. Northern blot analysis showed increased steady-state levels of KAI1 mRNA expression in 24 of 27 (89{\%}) pancreatic cancer samples. In situ hybridization showed enhanced KAI1 mRNA levels in the pancreatic cancer cells in 82{\%} cancer tissues. The stroma surrounding the cancer mass and normal pancreatic tissue adjacent to the cancer cells exhibited very low levels of KAI1 mRNA expression. Correlation of the mRNA levels obtained by Northern blot analysis with clinical parameters of the patients revealed that KAI1 mRNA levels were significantly higher (P <0.01) in earlier tumor stages (I, II), compared with advanced tumor stages (III, IV) in which lymph node or distant metastases were present. Furthermore, poorly differentiated tumors had significantly higher KAI1 mRNA levels than those that were moderately or well differentiated (P <0.05). No association between KAI1 expression and survival was found. Our results indicate that KAI1 mRNA expression is reduced in patients with advanced tumor stages. This suggests that reduction of KAI1 expression might enable pancreatic cancer cells to spread in lymph nodes and to distant organs.",
author = "Xiaozhong Guo and Helmut Friess and Graber, {Hans U.} and Mikiya Kashiwagi and Arthur Zimmermann and Murray Korc and B{\"u}chler, {Markus W.}",
year = "1996",
month = "11",
day = "1",
language = "English (US)",
volume = "56",
pages = "4876--4880",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "21",

}

TY - JOUR

T1 - KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases

AU - Guo, Xiaozhong

AU - Friess, Helmut

AU - Graber, Hans U.

AU - Kashiwagi, Mikiya

AU - Zimmermann, Arthur

AU - Korc, Murray

AU - Büchler, Markus W.

PY - 1996/11/1

Y1 - 1996/11/1

N2 - KAI1 is a metastasis suppressor gene for prostate cancer that is located on chromosome 11p11.2-13. Using Northern blot analysis and in situ hybridization, we studied expression of KAI1 mRNA in specimens from 14 normal pancreases and 27 primary pancreatic cancers, and then correlated the findings with the clinical and histopathological parameters of the patients. Northern blot analysis showed increased steady-state levels of KAI1 mRNA expression in 24 of 27 (89%) pancreatic cancer samples. In situ hybridization showed enhanced KAI1 mRNA levels in the pancreatic cancer cells in 82% cancer tissues. The stroma surrounding the cancer mass and normal pancreatic tissue adjacent to the cancer cells exhibited very low levels of KAI1 mRNA expression. Correlation of the mRNA levels obtained by Northern blot analysis with clinical parameters of the patients revealed that KAI1 mRNA levels were significantly higher (P <0.01) in earlier tumor stages (I, II), compared with advanced tumor stages (III, IV) in which lymph node or distant metastases were present. Furthermore, poorly differentiated tumors had significantly higher KAI1 mRNA levels than those that were moderately or well differentiated (P <0.05). No association between KAI1 expression and survival was found. Our results indicate that KAI1 mRNA expression is reduced in patients with advanced tumor stages. This suggests that reduction of KAI1 expression might enable pancreatic cancer cells to spread in lymph nodes and to distant organs.

AB - KAI1 is a metastasis suppressor gene for prostate cancer that is located on chromosome 11p11.2-13. Using Northern blot analysis and in situ hybridization, we studied expression of KAI1 mRNA in specimens from 14 normal pancreases and 27 primary pancreatic cancers, and then correlated the findings with the clinical and histopathological parameters of the patients. Northern blot analysis showed increased steady-state levels of KAI1 mRNA expression in 24 of 27 (89%) pancreatic cancer samples. In situ hybridization showed enhanced KAI1 mRNA levels in the pancreatic cancer cells in 82% cancer tissues. The stroma surrounding the cancer mass and normal pancreatic tissue adjacent to the cancer cells exhibited very low levels of KAI1 mRNA expression. Correlation of the mRNA levels obtained by Northern blot analysis with clinical parameters of the patients revealed that KAI1 mRNA levels were significantly higher (P <0.01) in earlier tumor stages (I, II), compared with advanced tumor stages (III, IV) in which lymph node or distant metastases were present. Furthermore, poorly differentiated tumors had significantly higher KAI1 mRNA levels than those that were moderately or well differentiated (P <0.05). No association between KAI1 expression and survival was found. Our results indicate that KAI1 mRNA expression is reduced in patients with advanced tumor stages. This suggests that reduction of KAI1 expression might enable pancreatic cancer cells to spread in lymph nodes and to distant organs.

UR - http://www.scopus.com/inward/record.url?scp=0029854919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029854919&partnerID=8YFLogxK

M3 - Article

C2 - 8895737

AN - SCOPUS:0029854919

VL - 56

SP - 4876

EP - 4880

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 21

ER -